Reviva Pharmaceuticals Holdings Inc. Ordinary Shares RVPH 深 沪
等待开盘 10-04 09:30:00 美东时间
0.5285
+0.041
+8.34%
华盛通- 最 高0.58
- 今 开0.5393
- 成交量 2052.49万股
- 最 低 0.49
- 昨 收 0.4878
- 总市值 5091.42万
- 52周最高 4.28
- 市盈率 静 --
- 换手率 0.02%
- 52周最低 0.2522
- 委 比 0.00%
- 总股本 9633.71万
- 历史最高 15.10
- 量 比 1.46
- 振 幅 18.45%
- 历史最低 0.00
- 每 手 1
- 风险率 0.55%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Why Actelis Networks Shares Are Trading Higher By Over 40%; Here Are 20 Stocks Moving Premarket
Shares of Actelis Networks Inc (NASDAQ:ASNS) rose sharply in pre-market trading...
10-03 17:32
Reviva to Participate in the 4th Annual Roth Healthcare Opportunities Conference
Reviva Pharmaceuticals, a late-stage biopharmaceutical company focused on addressing unmet medical needs in CNS, inflammatory, and cardiometabolic diseases, announced that its CEO, Laxminarayan Bhat, Ph.D., will participate in a panel discussion and host one-on-one investor meetings at the 4th Annual Roth Healthcare Opportunities Conference on October 9, 2025, in New York. The panel, titled “Small Firms Tackling Blockbuster Indications,” will tak...
10-02 12:00
美股大行评级 | 潜在涨幅207.38%！GoldMining获HC Wainwright升目标价至3.75美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持GoldMining"买入"评级，目标价从3.25美元升至3.75美元；摩根士丹利：维持Crinetics Pharmaceuticals"超配"评级，目标价从65美元升至77美元
09-30 14:16
Reviva Pharmaceuticals Amends Bylaws to Ease Quorum
Reviva Pharmaceuticals Holdings ( ($RVPH) ) has issued an update. On September ...
09-27 05:29
Reviva to Participate in the Lytham Partners Fall 2025 Investor Conference
Reviva Pharmaceuticals Holdings, Inc. announced that CEO Dr. Laxminarayan Bhat will present and host one-on-one investor meetings at the Lytham Partners Fall 2025 Investor Conference on September 30, 2025. The conference will be held virtually, with registration available via the provided link. Reviva, a late-stage biopharmaceutical company, focuses on developing therapies for CNS, inflammatory, and cardiometabolic diseases. The company's pipelin...
09-23 12:00
美股大行评级 | 潜在涨幅302.68%！Maxim Group上调T Stamp目标价至12美元，维持"买入"评级
今日重点评级关注：Maxim Group：维持T Stamp"买入"评级，目标价从8美元升至12美元；Maxim Group：维持Rezolute"买入"评级，目标价从15美元升至20美元
09-22 18:44
Reviva Pharmaceuticals Announces Public Offering to Raise Funds
Reviva Pharmaceuticals Holdings ( ($RVPH) ) has shared an announcement. On Sept...
09-20 05:44
Top 3 Health Care Stocks That May Explode In September
The most oversold stocks in the health care sector presents an opportunity to b...
09-19 19:01
Why FedEx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket
Shares of FedEx Corporation (NYSE:FDX) rose sharply in pre-market trading after...
09-19 17:25
Reviva Pharmaceuticals announces proposed public offering
Reviva Pharmaceuticals Holdings (NASDAQ:RVPH) on Thursday said it intends to offer shares of its common stock and warrants to purchase shares of common stock in a public offering. All of the securitie...
09-19 04:18
